title: Use of Ethibloc in the treatment of cystic and venous angiomas in children. 19 cases.
abstract: The authors report the use of Ethibloc in the treatment of cystic lymphangiomas and venous angiomas in 19 children. This embolizing product is injected by puncture in situ. Ten cystic lymphangiomas were treated, including 7 of the cervico-facial region. Of these ten, 8 were embolized initially using Ethibloc, and 2 after surgery. The diagnosis was always confirmed by echography and in some cases also by scanner. Six were completely cured and 2 had partial but satisfactory results requiring further injections. The final 2 cases when Ethibloc was administered after surgery, gave very disappointing results as the residual lesion was microcystic and thus difficult to access for the Ethibloc injection. The 9 venous angiomas involved various regions, including 5 facial lesions. These angiomas required a more extensive blood-clotting and radiologic assessment: standard radiography to detect the clot, Doppler echography and M.R.I. precisely clarifying the exact extension in depth. For 6 patients the cure was complete, for 2 others the results were good. Finally, in 1 case Ethibloc embolization was carried out prior to surgery, allowing definitive cure. In all, this technique resulted in a complete cure in 2/3 of the cases and its simplicity makes it a seemingly interesting alternative to surgery.
authors.affiliation: Service de Cardiologie Infantile, Hôpital Cardiologique CHR Lille, France.
authors.forename: G M
authors.initials: GM
authors.lastname: Brevière
authors.forename: M
authors.initials: M
authors.lastname: Bonnevalle
authors.forename: J P
authors.initials: JP
authors.lastname: Pruvo
authors.forename: R
authors.initials: R
authors.lastname: Besson
authors.forename: P
authors.initials: P
authors.lastname: Marache
authors.forename: P
authors.initials: P
authors.lastname: Herbaux
authors.forename: P
authors.initials: P
authors.lastname: Debeugny
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003973:Diatrizoate; D004338:Drug Combinations; D004621:Embolization, Therapeutic; D005227:Fatty Acids; D005260:Female; D005500:Follow-Up Studies; D006391:Hemangioma / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D007223:Infant; D008202:Lymphangioma / Q000175:diagnosis / Q000628:therapy*; D008297:Male; D011409:Propylene Glycols; D011506:Proteins; D012983:Soft Tissue Neoplasms / Q000175:diagnosis / Q000628:therapy*; D015028:Zein
chemical_list: D004338:Drug Combinations; D005227:Fatty Acids; D011409:Propylene Glycols; D011506:Proteins; D003973:Diatrizoate; D015028:Zein; C020481:alcoholic prolamine solution